Urologist Dr. Paul R. Kenworthy Designated a UroLift® Center of Excellence

The UroLift System has filled an unmet need for the 50% of men over 50 suffering from enlarged prostate.

Northwoods Urology of Texas today announced that Dr. Kenworthy has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Kenworthy has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH. Dr. Kenworthy is the first physician in Houston to be designated a UroLift Center of Excellence.

“The UroLift System has filled an unmet need for the 50% of men over 50 suffering from enlarged prostate,” says Dr. Kenworthy. “Patients are looking for long-term durable solutions that allow them to discontinue the use of ongoing medications. The UroLift System is the only treatment option available that is truly minimally invasive, allows men to stop taking medication, and provides rapid results. Northwoods Urology of Texas is thrilled to be a leading practice in the Houston area, offering the best treatment options available for our patients.”

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life. If left untreated, BPH obstruction may lead to further bladder and kidney problems.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *